Assisted Reproductive Technology Market
Assisted Reproductive Technology Market Size, Share & Trends Analysis by Technology (In Vitro Fertilization, Artificial Insemination (AI / IUI), Intracytoplasmic Sperm Injection (ICSI), Surrogacy, Cryopreservation / Embryo Freezing Technologies, Preimplantation Genetic Diagnosis/Screening (PGD/PGT), and Others (Gamete Intrafallopian Transfer), and by Procedure (Frozen Donor, Frozen Non-Donor, Fresh Donor, Fresh Non-Donor, and Embryo Banking), Forecast Period (2026-2035)
Industry Overview
Assisted reproductive technology market was valued at $4.3 billion in 2025 and is projected to reach $8.8 billion by 2035, growing at a CAGR of 7.5% during the forecast Period (2026-2035). The market growth is driven by rising infertility rates (resulting from lifestyle factors and delayed marriage), technological advancements (including IVF, PGT, and cryopreservation), increased awareness, and supportive policies. The Asia-Pacific region is emerging as the fastest-growing region, although high costs, ethical debates, and accessibility issues remain key challenges.
Market Dynamics
Rising Infertility Rates and Changing Lifestyle Patterns
A major driver of the ART market is the increasing prevalence of infertility across the globe. Factors such as delayed parenthood, obesity, stress, sedentary lifestyles, and exposure to environmental pollutants have contributed to rising infertility rates in both men and women. As more couples face reproductive challenges, the demand for ART procedures like in vitro fertilization (IVF), artificial insemination (IUI), and egg/sperm freezing has grown significantly. This trend is particularly pronounced in developed countries where lifestyle-related infertility is more prevalent, driving sustained market growth.
Technological Advancements and Innovation in ART Procedures
Advancements in reproductive technology are continuously enhancing the efficiency, precision, and success rates of ART treatments. Innovations such as time-lapse embryo imaging, preimplantation genetic testing (PGT), AI-assisted embryo selection, and improved cryopreservation techniques have increased treatment outcomes, making ART more appealing to patients. Additionally, digital solutions and integration of software for fertility tracking and predictive analytics are improving clinical decision-making. These technological improvements not only enhance patient confidence but also encourage clinics to adopt new equipment and solutions, fueling market expansion.
Growing Awareness, Social Acceptance, and Accessibility
Increasing awareness of fertility options, combined with changing societal attitudes toward family planning, is driving market growth. More individuals and couples, including single parents and same-sex couples, are seeking reproductive assistance due to greater social acceptance and reduced stigma. Government initiatives, insurance coverage, and fertility programs in certain regions are improving access to ART treatments, especially in developing countries. Public education campaigns and media exposure about fertility challenges and ART solutions have also contributed to increased patient adoption, further supporting market expansion.
Market Segmentation
- Based on the Technology, the market is segmented into in vitro fertilization, artificial insemination (AI / IUI), intracytoplasmic sperm injection (ICSI), surrogacy, cryopreservation/embryo freezing technologies, preimplantation genetic diagnosis/screening (PGD/PGT), and others (gamete intrafallopian transfer.
- Based on the procedure, the market is segmented into frozen donor, frozen non-donor, fresh donor, fresh non-donor, and embryo banking.
In Vitro Fertilization (IVF) Segment to Grow at a Considerable Market Share
Among the various segments of the global assisted reproductive technology (ART) Market, in vitro fertilization (ivf) stands out as the largest and leading technology segment, driving the majority of market growth. IVF has gained widespread adoption due to its high success rates, versatility in treating multiple causes of infertility, and continuous technological advancements such as time-lapse embryo monitoring, AI-assisted embryo selection, and integration with preimplantation genetic testing (PGT/PGD). These innovations have significantly improved clinical outcomes, making IVF the preferred choice for fertility clinics and patients alike. Other ART technologies, including Artificial Insemination (AI/IUI), Intracytoplasmic Sperm Injection (ICSI), and surrogacy, while important, collectively contribute less to overall market revenue compared to IVF.
Fresh Non-Donor: A Key Segment in Market Growth
Fresh non-donor procedures are emerging as the key growth segment. This procedure involves the use of freshly retrieved eggs from the patient herself, without relying on donor material, which offers higher success rates for patients with viable ovarian reserves. The rising preference for personalized fertility solutions, coupled with advancements in ovarian stimulation protocols and embryo transfer techniques, is driving demand for Fresh Non-Donor cycles.
Additionally, increasing awareness about fertility preservation and the growing trend of planned parenthood among women in their late reproductive years are contributing to market expansion. While Frozen procedures and Embryo Banking also show steady growth due to convenience and delayed use, Fresh Non-Donor cycles remain the most sought-after option, reflecting their critical role in the ART market’s growth trajectory.
Regional Outlook
the global assisted reproductive technology market is further divided by geography, including North America (the US and Canada), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), and the Rest of the World (the Middle East & Africa, and Latin America).
North America Region to Hold a Substantial Growth Rate
In North America, the US dominates the global assisted reproductive technology market, holding the largest market share due to a combination of advanced healthcare infrastructure, high awareness levels, and widespread adoption of fertility treatments. The country has a well-established network of fertility clinics, supported by stringent regulatory frameworks and reimbursement policies that facilitate access to ART services. Technological advancements in procedures such as In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), and cryopreservation have further enhanced treatment success rates, attracting both domestic and international patients. Additionally, growing infertility rates linked to delayed parenthood, lifestyle factors, and increasing prevalence of reproductive health disorders have fueled the demand for ART solutions in the US The presence of key market players, ongoing research and development initiatives, and investment in next-generation fertility technologies also contribute to its market leadership.
Furthermore, supportive government initiatives, awareness campaigns, and insurance coverage in certain states encourage couples to opt for assisted reproductive procedures. While other regions, such as Europe and Asia-Pacific, are witnessing rapid growth, the US continues to lead in terms of market size, technological adoption, and overall contribution to the global ART landscape.
Market Players Outlook
The major companies operating in the global assisted reproductive technology market include CooperSurgical Inc., Ferring B.V., FUJIFILM Irvine Scientific Inc., Merck KGaA, Vitrolife AB, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisitions to expand their businesses and develop innovative products to maintain their market positioning.
Recent Development
- In June 2025, IVI RMA Global, supported by KKR, planned to acquire ART Fertility Clinics for $400-450 million, enhancing its footprint in India's growing IVF market. This acquisition underscores IVI RMA's global expansion strategy, adding India to its extensive network of over 190 clinics across more than 15 countries.
- In July 2025, NewGen acquired cytometry technology and assets, including 18 cell-sorting systems, partially constructed units, and six patents on microfluidic systems, to bolster its U.S. expansion plans for NewGenSort services. This follows the earlier purchase of MicroSort technology for sperm cell separation before IVF, which utilizes advanced flow cytometry for precise sorting. The newly acquired systems will be deployed in the US, where the IVF market is experiencing growth, as evidenced by a rise in cycles and births from 2022 to 2023. NewGen expects to perform over 25,000 sorts annually and anticipates gross revenue exceeding $20 million once operational. Enhanced manufacturing capabilities will aid in market penetration, with technology rollout scheduled for Q1 2026.
The Report Covers
- Market value data analysis for 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global assisted reproductive technology market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global Assisted Reproductive Technology Market Sales Analysis – Technology | Procedure ($ Million)
- Assisted Reproductive Technology Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Assisted Reproductive Technology Market Trends
- Market Recommendations
- Porter's Five Forces Analysis for the Assisted Reproductive Technology Market
- Competitive Rivalry
- Threat of New Entrants
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Market Determinants
- Market Drivers
- Drivers For Global Assisted Reproductive Technology Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Global Assisted Reproductive Technology Market: Impact Analysis
- Market Opportunities
- Opportunities For Global Assisted Reproductive Technology Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Assisted Reproductive Technology Market Revenue and Share by Manufacturers
- Assisted Reproductive Technology Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- CooperSurgical Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Ferring B.V.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- FUJIFILM Irvine Scientific Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Merck KGaA
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Vitrolife AB
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- CooperSurgical Inc.
- Key Company Analysis
- Global Assisted Reproductive Technology Market Sales Analysis by Technology ($ Million)
- In Vitro Fertilization
- Artificial Insemination (AI / IUI)
- Intracytoplasmic Sperm Injection (ICSI)
- Surrogacy
- Cryopreservation / Embryo Freezing Technologies
- Preimplantation Genetic Diagnosis/Screening (PGD/PGT)
- Others (Gamete Intrafallopian Transfer)
- Global Assisted Reproductive Technology Market Sales Analysis by Procedure ($ Million)
- Frozen Donor
- Frozen Non-Donor
- Fresh Donor
- Fresh Non-Donor
- Embryo Banking
- Regional Analysis
- North American Assisted Reproductive Technology Market Sales Analysis – Technology | Procedure | Country ($ Million)
- Macroeconomic Factors for North America
- United States
- Canada
- European Assisted Reproductive Technology Market Sales Analysis – Technology | Procedure | Country ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia-Pacific Assisted Reproductive Technology Market Sales Analysis – Technology | Procedure | Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- Rest of Asia-Pacific
- Rest of the World Assisted Reproductive Technology Market Sales Analysis – Technology | Procedure | Country ($ Million)
- Macroeconomic Factors for the Rest of the World
- Latin America
- Middle East and Africa
- Company Profiles
- AdvaCare Pharma
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Bloom IVF Centre
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Cook Medical Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- CooperSurgical, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Cryolab Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Esco Micro Pte Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- European Sperm Bank
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Ferring B.V.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- FUJIFILM Irvine Scientific
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Genea Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Hamilton Thorne, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Igenomix
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Illumina, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Kitazato Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Merck KGaA
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Nidacon International AB
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Ovation Fertility
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Progyny Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Thermo Fisher Scientific, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Vitrolife AB
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- AdvaCare Pharma
1. Global Assisted Reproductive Technology Market Research and Analysis by Technology, 2025–2035 ($ Million)
2. Global In Vitro Fertilization Assisted Reproductive Technology Market Research and Analysis by Region, 2025–2035 ($ Million)
3. Global Artificial Insemination (AI / IUI) Assisted Reproductive Technology Market Research and Analysis by Region, 2025–2035 ($ Million)
4. Global Intracytoplasmic Sperm Injection (ICSI) Assisted Reproductive Technology Market Research and Analysis by Region, 2025–2035 ($ Million)
5. Global Surrogacy Assisted Reproductive Technology Market Research and Analysis by Region, 2025–2035 ($ Million)
6. Global Cryopreservation / Embryo Freezing Assisted Reproductive Technology Market Research and Analysis by Region, 2025–2035 ($ Million)
7. Global Preimplantation Genetic Diagnosis/Screening (PGD/PGT) Assisted Reproductive Technology Market Research and Analysis by Region, 2025–2035 ($ Million)
8. Global Other Assisted Reproductive Technology Market Research and Analysis by Region, 2025–2035 ($ Million)
9. Global Assisted Reproductive Technology Market Research and Analysis by Procedure, 2025–2035 ($ Million)
10. Global Frozen Donor Market Research and Analysis by Region, 2025–2035 ($ Million)
11. Global Frozen Non-Donor Market Research and Analysis by Region, 2025–2035 ($ Million)
12. Global Fresh Donor Market Research and Analysis by Region, 2025–2035 ($ Million)
13. Global Fresh Non-Donor Market Research and Analysis by Region, 2025–2035 ($ Million)
14. Global Embryo Banking Market Research and Analysis by Region, 2025–2035 ($ Million)
15. Global Assisted Reproductive Technology Market Research and Analysis by Region, 2025–2035 ($ Million)
16. North American Assisted Reproductive Technology Market Research and Analysis by Technology, 2025–2035 ($ Million)
17. North American Assisted Reproductive Technology Market Research and Analysis by Procedure, 2025–2035 ($ Million)
18. European Assisted Reproductive Technology Market Research and Analysis by Technology, 2025–2035 ($ Million)
19. European Assisted Reproductive Technology Market Research and Analysis by Procedure, 2025–2035 ($ Million)
20. Asia-Pacific Assisted Reproductive Technology Market Research and Analysis by Country, 2025–2035 ($ Million)
21. Asia-Pacific Assisted Reproductive Technology Market Research and Analysis by Technology, 2025–2035 ($ Million)
22. Asia-Pacific Assisted Reproductive Technology Market Research and Analysis by Procedure, 2025–2035 ($ Million)
23. Rest of the World Assisted Reproductive Technology Market Research and Analysis by Region, 2025–2035 ($ Million)
24. Rest of the World Assisted Reproductive Technology Market Research and Analysis by Technology, 2025–2035 ($ Million)
25. Rest of the World Assisted Reproductive Technology Market Research and Analysis by Procedure, 2025–2035 ($ Million)
1. Global Assisted Reproductive Technology Market Share By Technology, 2025 Vs 2035 (%)
2. Global In Vitro Fertilization Assisted Reproductive Technology Market Share By Region, 2025 Vs 2035 (%)
3. Global Artificial Insemination (AI / IUI) Assisted Reproductive Technology Market Share By Region, 2025 Vs 2035 (%)
4. Global Intracytoplasmic Sperm Injection (ICSI) Assisted Reproductive Technology Market Share By Region, 2025 Vs 2035 (%)
5. Global Surrogacy Assisted Reproductive Technology Market Share By Region, 2025 Vs 2035 (%)
6. Global Cryopreservation / Embryo Freezing Assisted Reproductive Technology Market Share By Region, 2025 Vs 2035 (%)
7. Global Preimplantation Genetic Diagnosis/Screening (PGD/PGT) Assisted Reproductive Technology Market Share By Region, 2025 Vs 2035 (%)
8. Global Other Assisted Reproductive Technology Market Share By Region, 2025 Vs 2035 (%)
9. Global Assisted Reproductive Technology Market Share By Procedure, 2025 Vs 2035 (%)
10. Global Frozen Donor Market Share By Region, 2025 Vs 2035 (%)
11. Global Frozen Non-Donor Market Share By Region, 2025 Vs 2035 (%)
12. Global Fresh Donor Market Share By Region, 2025 Vs 2035 (%)
13. Global Fresh Non-Donor Market Share By Region, 2025 Vs 2035 (%)
14. Global Embryo Banking Market Share By Region, 2025 Vs 2035 (%)
15. Global Assisted Reproductive Technology Market Share By Region, 2025 Vs 2035 (%)
16. US Assisted Reproductive Technology Market Size, 2025–2035 ($ Million)
17. Canada Assisted Reproductive Technology Market Size, 2025–2035 ($ Million)
18. UK Assisted Reproductive Technology Market Size, 2025–2035 ($ Million)
19. France Assisted Reproductive Technology Market Size, 2025–2035 ($ Million)
20. Germany Assisted Reproductive Technology Market Size, 2025–2035 ($ Million)
21. Italy Assisted Reproductive Technology Market Size, 2025–2035 ($ Million)
22. Spain Assisted Reproductive Technology Market Size, 2025–2035 ($ Million)
23. Russia Assisted Reproductive Technology Market Size, 2025–2035 ($ Million)
24. Rest Of Europe Assisted Reproductive Technology Market Size, 2025–2035 ($ Million)
25. India Assisted Reproductive Technology Market Size, 2025–2035 ($ Million)
26. China Assisted Reproductive Technology Market Size, 2025–2035 ($ Million)
27. Japan Assisted Reproductive Technology Market Size, 2025–2035 ($ Million)
28. South Korea Assisted Reproductive Technology Market Size, 2025–2035 ($ Million)
29. Australia And New Zealand Assisted Reproductive Technology Market Size, 2025–2035 ($ Million)
30. ASEAN Economies Assisted Reproductive Technology Market Size, 2025–2035 ($ Million)
31. Rest Of Asia-Pacific Assisted Reproductive Technology Market Size, 2025–2035 ($ Million)
32. Latin America Assisted Reproductive Technology Market Size, 2025–2035 ($ Million)
33. Middle East And Africa Assisted Reproductive Technology Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of user within the company
Contact Sales
FAQS
The size of the Assisted reproductive technology market in 2025 is estimated to be around $4.3 billion.
North America holds the largest share in the Assisted reproductive technology market.
Leading players in the Assisted reproductive technology market include CooperSurgical Inc., Ferring B.V., FUJIFILM Irvine Scientific Inc., Merck KGaA, Vitrolife AB, among others.
The Assisted reproductive technology market is expected to grow at a CAGR of 7.5% from 2026 to 2035.
The Assisted Reproductive Technology Market is driven by rising infertility rates and increasing adoption of advanced fertility treatments.
